PMC:7696151 / 42941-44012
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1216 | 434-439 | Species | denotes | women | Tax:9606 |
| 1217 | 830-834 | Species | denotes | rats | Tax:10116 |
| 1218 | 480-483 | Chemical | denotes | HCQ | MESH:D006886 |
| 1219 | 792-795 | Chemical | denotes | HCQ | MESH:D006886 |
| 1220 | 0-20 | Disease | denotes | Rheumatoid arthritis | MESH:D001172 |
| 1221 | 35-53 | Disease | denotes | autoimmune disease | MESH:D001327 |
| 1222 | 80-92 | Disease | denotes | inflammation | MESH:D007249 |
| 1223 | 170-190 | Disease | denotes | rheumatoid arthritis | MESH:D001172 |
| 1224 | 249-259 | Disease | denotes | rheumatoid | MESH:D011695 |
| 1225 | 389-409 | Disease | denotes | rheumatoid arthritis | MESH:D001172 |
| 1226 | 537-550 | Disease | denotes | hyperactivity | MESH:D006948 |
| 1227 | 674-683 | Disease | denotes | Jancinova | |
| 1228 | 849-858 | Disease | denotes | arthritis | MESH:D001168 |
| 1229 | 1053-1065 | Disease | denotes | inflammation | MESH:D007249 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T61 | 0-20 | Phenotype | denotes | Rheumatoid arthritis | http://purl.obolibrary.org/obo/HP_0001370 |
| T62 | 35-53 | Phenotype | denotes | autoimmune disease | http://purl.obolibrary.org/obo/HP_0002960 |
| T63 | 119-139 | Phenotype | denotes | Immune dysregulation | http://purl.obolibrary.org/obo/HP_0002958 |
| T64 | 170-190 | Phenotype | denotes | rheumatoid arthritis | http://purl.obolibrary.org/obo/HP_0001370 |
| T65 | 389-409 | Phenotype | denotes | rheumatoid arthritis | http://purl.obolibrary.org/obo/HP_0001370 |
| T66 | 537-550 | Phenotype | denotes | hyperactivity | http://purl.obolibrary.org/obo/HP_0000752 |
| T67 | 849-858 | Phenotype | denotes | arthritis | http://purl.obolibrary.org/obo/HP_0001369 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T280 | 0-118 | Sentence | denotes | Rheumatoid arthritis is a systemic autoimmune disease, characterized by chronic inflammation and damage to the joints. |
| T281 | 119-349 | Sentence | denotes | Immune dysregulation underlies the pathogenesis of rheumatoid arthritis, leading to uncontrolled production of antibodies, mainly rheumatoid factor and citrullinate, involved in the autoreactivity against cartilage and bone [117]. |
| T282 | 350-446 | Sentence | denotes | It is estimated that the prevalence of rheumatoid arthritis is around 1%, mainly in women [118]. |
| T283 | 447-622 | Sentence | denotes | The immunosuppressive effects of HCQ are due to the ability to modulate T-cell and B-cell hyperactivity, resulting in a reduction of pro-inflammatory cytokine gene expression. |
| T284 | 623-859 | Sentence | denotes | As the involvement of neutrophils in this disease, Jancinova, Pazourekova, Lucova, Perecko, Mihalova, Bauerova, Nosal and Drabikova [75] investigated the impact of oral HCQ administration on these cells, in rats with adjuvant arthritis. |
| T285 | 860-1071 | Sentence | denotes | At doses of 40 mg/kg daily, per oral administration (p.o.), it strongly decreased the blood concentration of neutrophil-derived oxidants, involved in the tissue damage and the onset of chronic inflammation [75]. |